Effect of glycemic gap on short term outcome in critically ill patient: In zagazig university hospitals
| Autor: | Maisoon M. Eltohamy, Mohamed S.S. Saad, Arafa M. Elshabrawy, Farid Fawzy |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Blood Glucose
Male medicine.medical_specialty Cross-sectional study Endocrinology Diabetes and Metabolism Critical Illness 030209 endocrinology & metabolism Physical examination Severity of Illness Index 03 medical and health sciences 0302 clinical medicine Diabetes mellitus Outcome Assessment Health Care Internal Medicine Medicine Humans Medical history Glycemic APACHE Glycated Hemoglobin APACHE II medicine.diagnostic_test business.industry Critically ill 030208 emergency & critical care medicine General Medicine Middle Aged University hospital medicine.disease Prognosis Survival Rate Intensive Care Units Cross-Sectional Studies Diabetes Mellitus Type 1 Diabetes Mellitus Type 2 ROC Curve Hyperglycemia Emergency medicine Female business Biomarkers Follow-Up Studies |
| Zdroj: | Diabetesmetabolic syndrome. 13(2) |
| ISSN: | 1878-0334 |
| Popis: | Both admission Blood glucose and previous glycemic state may affect critically ill patients; So Glycemic gap may be a good indicator of ICU outcomes. This study investigated the effect of glycemic gap on short term outcome in critically ill patient and the value of incorporation of the Glycemic Gap into the APACHE-II on its discriminative performance. Subjects and Methods This cross sectional study was conducted in medical ICU of Zagazig University Hospitals, March 2018 to September 2018; total numbers of 240 critically ill patients admitted to ICU were enrolled in. All of them were subjected to: full history taking, clinical examination, routine investigations, random blood sugar, hemoglobin A1c. ADAG, Glycemic Gap and APACHE II were calculated. Results Elevated glycemic gap was associated with an increased ICU mortality and APACHE-II score was a good predictor of ICU mortality in critically ill patients. Conclusions Elevated glycemic gap was significantly associated with an increased ICU mortality that the glycemic gap can be used to assess the severity and prognosis of critically ill patients and their incorporation into the APACHE II score has increased its performance as a predictor of mortality. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect